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Margaret W. Egar ‡, Deborah A. Sarria, Denise Slayback-Barry, Teri Belecky-Adams and
Ellen A. G. Chernoff*
Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States
A previously unreported population of foam cells (foamy macrophages) accumulates in
the invasive fibrotic meninges during gap regeneration of transected adult Axolotl spinal
cord (salamander Ambystoma mexicanum) and may act beneficially. Multinucleated
giant cells (MNGCs) also occurred in the fibrotic meninges. Actin-label localization
and transmission electron microscopy showed characteristic foam cell and MNGC
podosome and ruffled border-containing sealing ring structures involved in substratum
attachment, with characteristic intermediate filament accumulations surrounding nuclei.
These cells co-localized with regenerating cord ependymal cell (ependymoglial)
outgrowth. Phase contrast-bright droplets labeled with Oil Red O, DiI, and DyRect
polar lipid live cell label showed accumulated foamy macrophages to be heavily
lipid-laden, while reactive ependymoglia contained smaller lipid droplets. Both cell types
contained both neutral and polar lipids in lipid droplets. Foamy macrophages and
ependymoglia expressed the lipid scavenger receptor CD36 (fatty acid translocase) and
the co-transporter toll-like receptor-4 (TLR4). Competitive inhibitor treatment using the
modified fatty acid Sulfo-N-succinimidyl Oleate verified the role of the lipid scavenger
receptor CD36 in lipid uptake studies in vitro. Fluoromyelin staining showed both cell
types took up myelin fragments in situ during the regeneration process. Foam cells
took up DiI-Ox-LDL and DiI-myelin fragments in vitro while ependymoglia took up only
DiI-myelin in vitro. Both cell types expressed the cysteine proteinase cathepsin K, with
foam cells sequestering cathepsin K within the sealing ring adjacent to the culture
substratum. The two cell types act as sinks for Ox-LDL and myelin fragments within the
lesion site, with foamy macrophages showing more Ox-LDL uptake activity. Cathepsin
K activity and cellular localization suggested that foamy macrophages digest ECM
within reactive meninges, while ependymal cells act from within the spinal cord tissue
during outgrowth into the lesion site, acting in complementary fashion. Small MNGCs
also expressed lipid transporters and showed cathepsin K activity. Comparison of 3H-
glucosamine uptake in ependymal cells and foam cells showed that only ependymal
cells produce glycosaminoglycan and proteoglycan-containing ECM, while the cathepsin
studies showed both cell types remove ECM. Interaction of foam cells and ependymoglia
in vitro supported the dispersion of ependymal outgrowth associated with tissue
reconstruction in Axolotl spinal cord regeneration.
Keywords: foam cells, foamymacrophages, ependymal cells, meningeal fibrosis, spinal cord regeneration, axolotl
regeneration, lipid uptake, myelin uptake
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INTRODUCTION
This research examines a previously unidentified phenomenon
in spinal cord regeneration involving the accumulation of
foamy macrophages in fibrotic meninges during amphibian
spinal cord regeneration. In the transected spinal cord, during
gap regeneration, of the adult Axolotl (an aquatic salamander,
Ambystoma mexicanum) foamy macrophages took up lesion site
lipids and myelin while degrading ECM. These innate immune
system cells were also found in close association with Axolotl
ependymal cell (ependymoglial) outgrowth that remodels the
cord following injury. The interaction of foamymacrophage with
ependymal cells in vitromodified ependymal cell behavior related
to mesenchymal outgrowth.
The role of ependymal cells has been investigated extensively
in urodele spinal cord regeneration. Studies include ependymal
growth factor and retinoid responses, ECM formation and
removal, cytoskeletal changes, remodeling of radial processes
and epithelial to mesenchymal transition, association with axonal
outgrowth, stem cell properties and neurogenesis, and dorsal-
ventral patterning of the regenerating cord (1–17). The role
of a meningeal reaction in urodele spinal cord regeneration
has a far less extensive body of work (5, 12, 13). The present
research explores aspects of the urodele spinal meninges response
complementary to the earlier studies.
Meningeal fibrosis occurs after penetrating spinal cord injury
(SCI) in urodele amphibians (newts and salamanders), as it does
in mammals [rev. (10, 15)]. Penetrating mammalian SCI induces
a meningeal (fibrotic) scar that inhibits axonal regrowth directly
and reinforces the astrocytic (gliotic) scar (18, 19). This dual
scarring process forms a permanent barrier to axonal regrowth.
In urodeles, fibrotic meninges is remodeled and excluded to the
periphery of regenerating cord, a process that involves ependymal
outgrowth and digestion of extracellular matrix (10, 12, 15, 20).
Stensaas (5) and Zukor et al. (12) showed an intimate association
of reactive meninges with multiple cell types in transected newt
spinal cord. Reactive newt meninges and cord outgrowth were
shown to containmacrophages that contact regenerating neurons
and ependymoglia during the regenerative process (12).
Foamy macrophages, also known as foam cells, foamy
phagocytes or foamy histiocytes, are of monocyte origin
and distinguished by the “foamy” appearance of their
extensive lipid inclusions in histological preparations
(21, 22). They can fuse into “osteoclast-like” MNGCs
(21, 23, 24). Foamy macrophages can serve as sinks for
lipoproteins and myelin fragments in pathological neural
conditions, such as multiple sclerosis (21, 25–27). They
can be, at least transiently, beneficial in this pathology
(22, 27).
Foamy macrophages form from monocyte-derived M2-
macrophage (anti-inflammatory macrophage) precursors (26, 28,
29). Features of foam cells in vivo and in vitro include: clusters of
lipid inclusions that are phase contrast bright, stain with Oil Red
O or the indocarbocyanine dye DiI, production of the cysteine
proteinase cathepsin K, activity of the lipid scavenger receptor
CD36, uptake of oxidized low density lipoprotein (Ox-LDL), and
uptake of myelin fragments. These features are characteristic of
live cell lipid droplets, foam cells and osteoclast-like MNGCs
derived from foam cells (21, 25–27, 30–33).
In mammalian SCI, foamy macrophages form only within
injured spinal cord tissue, where they take up myelin
and contribute to a pro-inflammatory environment (34).
Accumulation of foamy macrophages has not been shown within
injured mammalian spinal meninges (34, 35). Macrophages have
been described within injured salamander spinal cord, as well,
and many immune responsive genes are upregulated shortly
after Axolotl SCI (12, 36, 37). However, foamy macrophages have
not previously been reported in salamander cord or meninges.
Uptake of the toxic lipid metabolites after neural injury can
be approximated in vitro by uptake of Ox-LDL (38). A common
lipid transport mechanism involved in the uptake of Ox-LDL
uses CD36, a class B scavenger receptor/fatty acid translocase
(25, 39). In atherosclerosis and other pathological conditions,
CD36 and Toll-like Receptor-4 (TLR4), along with TLR6, act
together in lipid uptake and inflammatory behavior (40). CD 36 is
also involved in fusion of macrophages to formMNGCs (23, 24).
These studies suggest the use of an Ox-LDL uptake model and
examination of the role of CD36 in Axolotl meningeal foam cell
lipid transport.
In many neural pathologies, foamy macrophages andMNGCs
also take up myelin sheath products by phagocytosis. Myelin
debris persists for extended periods in mammalian spinal cord
lesion sites and is sequestered in macrophages (41, 42). Extensive
myelin fragment uptake by foamy macrophages occurs within
active and chronic-active plaques in the CNS in multiple sclerosis
(25–27, 43). In animal models of amyotrophic lateral sclerosis,
foamy macrophages are involved in myelin uptake during
Wallerian degeneration in the peripheral nerves, associated with
loss of axons and neuromuscular synapses (44–46). In Charcot-
Marie-Tooth disease, a group of peripheral nervous system
(PNS) demyelinating disorders, foamy macrophages with myelin
inclusions are found next to poorly myelinated or demyelinated
axons (47). Foamy, myelin-containing macrophages are also
found in association with peripheral nerve degeneration in
aging mice (48). In some of these pathologies the literature
is contradictory on the pro-inflammatory or anti-inflammatory
nature of the foam cells involved in this processes, depending on
the type of experimental system, stage of disease or the markers
examined (27, 46, 47, 49–51). The question whether these foam
cell effects are beneficial or harmful is even more complex. The
work presented here showed uptake of myelin in situ and in vitro
similar to that in seen in mammalian neural pathologies.
A third critical property of foamymacrophages in the nervous
system, in addition to oxidized lipoprotein and myelin uptake,
is their ability to degrade ECM (32). This process appears to
be universal in foamy macrophages and occurs in osteoclast-
like MNGCs associated with atherosclerosis and MNGC tumors
(52, 53). Foamy macrophages and MNGCs digest ECM using
cathepsin K and MMP9 as major secreted proteolytic factors
(32, 52–55). Secreted proteases can be concentrated on thematrix
within the sealing ring, a set of cytoskeletal and membrane
specializations also seen in osteoclasts (24, 32). The examination
of foamy macrophage and ependymal cathepsin K expression
extends our prior studies of matrix proteinase activity from
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FIGURE 1 | Collagen and proteoglycan stains in regenerating and control adult axolotl spinal cord. (A) A cross-section of intact adult axolotl spinal cord labeled with
trichrome stain. Red arrows show denticulate ligaments, a pial extension stained with aniline blue (collagen). Thin meningeal layers are present, collagen stained blue
(blue arrowheads). (B) Spinal cord wholemount labeled with mentanil yellow (collagen) and alcian blue (acidic proteoglycans). Arrow shows a nerve root. (C) Unstained
lesioned cord regenerated for 18 days, backlit stereoscopic view. Arrow shows a mass of ECM that joins the proximal and distal regenerating stumps. (D) Parasagittal
paraffin section through 14D regenerating cord stained with trichrome. (E) Mentanil yellow and alcian blue label in 14D regenerating cord. The arrows indicate
lipid-laden cells that appear orange against the stained ECM. (F) Regenerating spinal cord stained with alcian blue and the tissue dissected in the parasagittal plane.
Lipid-laden cells in the fibrotic ECM are indicated by arrows. (G) Paraffin sections of a regenerating 14D cord with DAPI nuclear label. Stump region with reactive
meninges. Dashed square indicates area at higher magnification in (H). (H) DAPI-labeled nuclei in 14D regenerating cord. Arrows show a group of multinucleated cells
present in the meninges. The white dashed lines in (C,E,F) indicate the site margin of harvested tissue for explants culture. Axo, axolotl; Regen, regenerating;
Parasag, parasaggital; D, day; DIC, differential interference contrast. Magnification bar is shown in the lower portion of each image.
ependymal cells in Axolotl spinal cord regeneration by Chernoff
et al. (20).
The studies reported here characterize distribution and
functionality of foamy macrophages and some MNGCs in
the injury-reactive Axolotl spinal cord meninges, starting
at the histological level. In transected adult Axolotl body-
region (non-tail) cord, transmission electron microscopic (TEM)
morphological studies, plus collagen and proteoglycan staining,
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show that interstitial meningeal ECM fills the lesion site
and wraps the regenerating transected stumps. DiI labeling
identify lipid-laden mononucleated cells attached to the fibrotic
meningeal ECM. Within the lesion site, lipid-laden and
multinucleated cells share ECM-filled space with the reactive
ependymal cells that grow out from the spinal cord. Transmission
electron microscope (TEM) studies show co-localization of
foamy macrophages and reactive ependymal cells within lesion
site fibrillar collagen. A primary tissue culture system uses
lipid stains to identify neutral and polar lipids. Functional
studies indicate that the foamymacrophages and some associated
MNGCs take up lipid via the scavenger receptor CD36,
co-expressed with toll-like receptor 4 (TLR4), and produce
cathepsin K.
Our studies are the first to indicate that foamy macrophages
are present in reactive Axolotl spinal cord meninges and
participate in spinal cord regeneration.
METHODS AND MATERIALS
Surgery and Tissue Culture
Surgery
Axolotls were obtained from the Ambystoma Genetic Stock
Center, University of Kentucky and maintained at 20–22◦C
in 20% Holtfreter’s Salts Solution. Transdermal anesthetic
tricaine methane sulfonate (Finquel; Syndel, Formerly Western
Chemical) was used in 20% Holtfreter’s Salts Solution, with
thimerosal for disinfection of the surgical field (5 ml/L of a 20
g/L 88% ethanol thimerosal stock), adjusted to pH 7 with sodium
bicarbonate. Finquel concentration was adjusted for the size of
the animal. Animals were anesthetized in 0.5 g/l Finquel for
adult; >20 cm, 2–3 years old; 0.3 g/L for juveniles; 10–15 cm,
6 months old. Before surgery, animals were injected with the
antibiotic Amikacin (2.5 mg/ml, 0.75ml for an adult; 0.5ml
for a juvenile). The lesioning procedure is described in detail
in Chernoff et al. (56) and will not be repeated here. Post-
surgically, lesioned-cord animals were treated in 20% Holtfreter’s
solution at 12◦C in a BOD incubator for 3 days, with daily
water changes and amikacin injections, then kept at 20–22◦C in
the vivarium through the regeneration process. All husbandry,
surgery, analgesia, and euthanasia was performed following the
IUPUI School of Science IACUC approved protocol SC 280R.
Tissue Culture
For these experiments sets of four to six animals, either sex,
age matched, but any color morph, were lesioned. Explants were
isolated following the procedure described in Chernoff et al. (56)
and O’Hara and Chernoff (6). Two weeks outgrowth (see dashed
lines in Figure 1) was isolated, cut to size and cultured on poly-D-
lysine/fibronectin-coated dishes. Explants were divided among
2–3 dishes. Each experiment was repeated at least three times.
Culture contained Leibovitz L-15 medium, 5mM Hepes Buffer,
and progesterone 20 nM. Finally a stock solution containing
5µg/ml insulin, 100µg/ml transferrin, 100µM putrescine, and
30 nM selenium was added (Sigma Chemical). EGF 20 ng/ml,
1% axolotl serum, and 1% Pen-Strep/Fungizone (Gibco) was
added to L-15 medium, which was used for the cultures. pH was
adjusted to 7.6.
Culture Dish Preparation
Thirty-five millimeter polystyrene tissue culture dishes were
coated with 100µg/ml poly- D -lysine in HEPES-buffered saline
solution, pH 7.4. The dishes were incubated at 37◦C for at least
30min, then rinsed twice with HEPES buffered saline pH 7.4.
Fibronectin (75µg/ml) was added to each dish and incubated
at 37◦C for 1 h and rinsed with HEPES buffered saline. HEPES
buffered saline contains 0.01M HEPES, 0.01M KCl, and 0.013M
NaCl in water, adjusted to pH 7.4. The dishes were rinsed with
medium prior to addition of explants.
Histological Stains
Wholemount
Animals were anesthetized and 3 cm spinal column segments
were excised fixed in 4% paraformaldehyde, pH 7.4 on a rocker
platform at room temperature for 20min, then overnight at 4◦C.
After rinsing in Hanks’ BSS, the tissue was incubated for 1 day
in 0.5% neutral calcium chelator EGTA to soften bone, rinsed in
HBSS and the spinal cord removed.
To identify the ECM collagen and proteoglycan wholemount
segments of axolotl spinal cord were stained. Proteoglycan was
stained with alcian blue alone. Collagen and proteoglycan were
co-stained with metanil yellow and alcian blue. Samples were
stained in alcian blue for 5min, and in metanil yellow for 1min.
After staining, samples were rinsed briefly in three changes of
10% ethanol for 5min to remove excess dye.
All samples were viewed and photographed in their whole-
mount state using a Nikon stereomicrocope and photographed
using a Nikon DXM-F digital camera system.
Trichrome Stain
Slides with paraffin sections were deparaffinized in xylene,
twice for 5min each. The slides were then placed in decreasing
concentrations of ethanol, then distilled water for 30 s at
each step. Deparaffinized slides were stained using Weigert’s
iron hematoxylin, followed by Biebrich scarlet-acid fuchin
and phosphotungstic/phosphomolybdic acid following kit
instructions (Sigma Chemical Co.). Slides were then soaked for
5min in aniline blue. After the finally staining step, the slides
are placed in 1% acetic acid for 2min, twice, then rinsed in
distilled water for 5min, twice. Finally, slides are dehydrated and
cleared in increasing concentrations of ethanol and finally xylene
for 10min in each solution. Histomount (Pella) permanent
mounting medium is then used to mount the slides.
Transmission Electron Microscopy
Animals were anesthetized and either perfused, or spinal cord
segments were fixed in situ for several minutes in cacodylate-
buffered tri-aldehyde fixative (57). Tissue was removed and
fixation continued in Kalt’s fixative for 24 h. Tissue was post-fixed
in buffered 2% osmium tetroxide, dehydrated, and embedded
in araldite epoxy resin. Plastic-embedded tissue was sectioned
on a Porter-Blum MT-2 ultra-microtome with glass knives for
1-micron sections, or with a diamond knife for thin sections.
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Thick sections were collected on glass slides and stained with 1%
toluidine blue. Thin sections (50–80 nm) were made at selected
intervals, collected on bare grids or on Padget-film-supported-1-
hole grids, stained with lead-citrate, and examined with a Tecnai
G2 12 Bio Twin (FEI, Hillsboro, OR) equipped with AMT CCD
Camera (AdvancedMicroscopy Techniques, Danvers, MA). Two
older images were obtained using a Philips 400 transmission
electron microscopy.
Actin Staining
Samples were fixed in 4% paraformaldehyde in HBSS for 20min.
Fixative was rinsed out with multiple changes of Hanks’ Balanced
Salts Solution (HBSS) pH 7.6. Cultures were permeabilized for
5min with 0.1% Triton-X-100 in HBSS. Wholemount samples
were permeabilized for 10min. Triton-X-100 was removed
with three 5min distilled water rinses. Rhodamine-Phalloidin
(Invitrogen) stock was prepared in methanol as directed, diluted
1:200 into the sample buffer and used at a concentration of 1.5
units/ml. Cultures were incubated for 10min and wholemount
samples were incubated for 20min, then rinsed in HBSS twice,
10min each. HBSS was removed and DAPI/antifade (Invitrogen)
added to cover the samples in small culture dishes, which were
coverslipped and viewed.
Lipid Labels and Inhibitor
DiI Staining
Cell cultures were fixed with 4% paraformaldehyde at room
temperature for 20min, rinsed in HBSS, then incubated with DiI
(1 mg/ml in 100% ethanol) for 15min. Dishes were rinsed briefly
in ethanol to remove unbound DiI. Cultures were incubated
in HBSS for 1 h to allow DiI to partition from membranes
to lipid droplets. Antifade with DAPI (Invitrogen) was added,
cultures coverslipped and viewed with a Nikon Eclipse TE 2000-
U inverted phase contrast and fluorescence microscope.
Oil Red O Staining
For neutral lipid staining, a stock solution of Oil Red O (Sigma
Aldrich) was prepared by dissolving 0.25 g/40ml of 2-propanol.
Solution was warmed at 37◦C to dissolve the dye. Before use,
a 3:2 dilution of the dye/propanol was made with water and
0.22micron filtered.Working solutionwas prepared immediately
before use. Cultures were fixed in paraformaldehyde, rinsed
in HBSS, then water. After a brief rinse with 60% 2-propanol
the working dye solution was added for 1–2min. Staining was
observed on an inverted microscope. Dye was removed, dishes
briefly rinsed once with 60% 2-propanol then distilled water
(10min) and digital images captured.
Polar Lipid Live Stain
To visualize neutral and polar lipids together, the DyRect Live-
Cell Neutral Lipid Imaging Kit (Marker Gene Technologies, Inc.)
was used. In this live foam cell stain, neutral lipids fluoresce green
and polar lipids fluoresce red. The green fluorescence overlaps
with green autofluorescence in our cells, so only the polar lipid
staining properties were useful. DyRect reagent was reconstituted
in ethanol at 1 mg/ml and diluted to 1µg/ml in culture medium
immediately before use. The dye-medium containing cultures
were incubated at room temperature for 1 h, rinsed in HBSS and
imaged live.
Ox-LDL Uptake
DiI-labeled Ox-LDLs (Invitrogen L3482) were diluted to 25
ug/ml in E3 medium (see Axolotl Tissue Culture section for
composition) and applied to cultures for 24 h. The cultures
were rinsed with HBSS and fresh medium was applied before
observation via fluorescence microscopy.
CD36 Inhibition
CD36 inhibition medium was created by adding sulfo-N-
succinimidyl oleate to E3 medium at a final concentration of
100 uM. Culture dishes were incubated with the CD36 inhibition
media for 24 h, then DiI labeled Ox-LDLs (25 ug/ml) were added
to the dish for 24 h incubation. Culture dishes were rinsed with
HBSS, and fresh E3 media was added before observation under
fluorescence microscopy.
Glucosamine Uptake, Autoradiography
For glucosamine uptake experiments, explant cultures were
established and grown for 6 days. Five µCi (185 µBq) of D-
[6-3H(N)]-glucosamine (Perkin-Elmer) was added per ml of
E3 medium and the cultures were incubated for 24 h. Labeled
medium was removed and cultures rinsed three times in HEPES
buffered saline, fixed in ice-cold 5% acetic acid in ethanol for
10min at 4◦C, rinsed three times with 100% ethanol, and air
dried. The dry plates were coated with 0.5ml Kodak-NB2 nuclear
tracking emulsion (Eastman Kodak Co) and allowed to expose
for 2 weeks at 4◦C in a light-tight box containing desiccant. After
2 weeks the plates were brought to room temperature, developed
with Kodak D-19 developer for 10min at room temperature,
rinsed, fixed with Kodafix (diluted 1: 3) for 10min, rinsed again,
and allowed to air dry. Coverslips were applied to the dishes with
Histomount permanent mounting medium (Ted Pella).
Immunohistochemistry
Paraffin Sections
Dissected tissues were fixed in 4% paraformaldehyde in HBSS,
pH 7.6, at 4◦C for at least 1 h, rinsed in HBSS and dehydrated in
a graded ethanol series, followed by two xylene rinses, paraffin
penetration and paraffin embedding. The sections were cut to
10µm thickness by microtome and “baked” at 60◦C overnight
onto Superfrost/Plus Microscope glass slides (Fisher). After
deparaffinizing and rinsing with PBT (phosphate-buffered saline,
PBS, plus 0.1% Tween-20), the sections were placed in 90◦C
0.01M citrate buffer (pH 6.0) for 10min, for post-fixation antigen
recovery, unless otherwise noted. Sections were then treated
with blocking buffer as follows: PBT with 10% normal goat
serum (NGS), diluted 1:1 with Superblock (Pierce Chemical).
Primary antibody was added in HBSS and incubated overnight
at 4◦C. After rinsing three times with HBSS, sections were
incubated with Alexa Fluor 594 secondary antibody (1:2,000,
Invitrogen) for 2 h at room temperature. CD36 antibody (R&D
SystemsMAB25191) was diluted to 2.5 ug/ml. After washing with
HBSS twice, sections were mounted in SlowFade Gold antifade
reagent with DAPI as the nuclear counterstain (Invitrogen) and
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coverslipped. Specimens were observed with a Nikon Eclipse
E800 fluorescence/DIC microscope.
Cell Cultures
Culture dishes were fixed with 4% paraformaldehyde for 30min
at room temperature and rinsed three times with HBSS before
incubation in SuperBlock blocking buffer in PBS (Thermo).
Dishes were rinsed three times with HBSS, and the appropriately
diluted primary antibody applied and incubated overnight. Then
dishes were rinsed three times with HBSS, and Alexa Flour
595 secondary antibody was applied and incubated for 2.5 h,
rinsed three times with HBSS, mounted in SlowFade Gold
antifade reagent with DAPI and coverslipped. Specimens were
observed with aNikon Eclipse TE 2000-U inverted phase contrast
and fluorescence microscope or a Keyence BZ-X Fluorescence,
phase, DICMicroscope. TLR4 polyclonal Ab (Novus Bio NB100-
56580SS) and TLR4 polyclonal Ab (Novus Bio NB100-56581SS)
were diluted to 5 ug/mL in HBSS. CD36 Ab (R&D Systems
MAB25191), and CD36 Ab (Novus Bio NB400-145SS) were
diluted to 2.5 ug/mL in HBSS. Cathepsin K Ab (Abcam ab19027)
was applied at 1:75 dilution in HBSS (antibody information
shown in table form in Supplemental Figure 1).
Myelin Experiments
Extraction and Labeling
Twelve axolotl brains were isolated and homogenized in a
0.32M sucrose solution with a sterile plastic pestle in 1.5ml
microcentrifuge tubes. The homogenate was layered over a
0.8M sucrose solution and centrifuged at a G-force of 16,000
(Sorvall Biofuge Pico, radius = 8.5 cm, 13,000 rpm) for 15min.
The myelin was collected at the interface of the two sucrose
solutions. 1,1′-dioctadecyl-3,3,3′3′-tetramethylindocarbocyanine
perchlorate (DiI) in ethanol (1 mg/mL) was applied to the
myelin extract and incubated for 30min at RT. The labeled
myelin extract was rinsed three times with HBSS to remove any
unbound DiI.
Endogeneous Myelin Staining
Fluoromyelin Red (Fisher F34652) was added at 1/300 dilution
in HBSS to fixed cultures and incubated for 40min then
rinsed in HBSS. DAPI and antifade (Invitrogen) was added
to the dishes and coverslipped. Cultures were imaged with
fluorescence microscopy.
Myelin Uptake
DiI-labeled myelin extract (100 µL/2ml culture medium) was
added to the 35mm dish cultures and incubated for 48 h. Dishes
were rinsed with HBSS and new E3 media added before cultures
were observed by fluorescence microscopy.
Statistical Analysis
Ninety-two unique photographic fields from >16 cultured
explants in untreated controls from seven separate untreated
regeneration control experiments were compiled and sorted into
categories of outgrowth: condensed ependymal outgrowth with
no foam cells, condensed ependymal outgrowth with foam cells,
dispersed ependymal cells with foam cells, dispersed ependymal
cells without foam cells and mixed forms. Each form was
tabulated for each of the seven experiments. Using Graphpad
Prism, A one-way analysis of variance (ANOVA) with Tukey’s
post-hocMultiple Comparisons Test was performed. In this type
of analysis significance is first determined by ANOVA, then an
stricter adjusted p-value is determined for each comparison (58).
RESULTS
Overview of Meninges, Meningeal Matrix,
and Foamy Macrophages
The results provide a structural overview of the organization of
reactive Axolotl meninges, fibrotic ECM and associated foamy
macrophages and MNGCs. Control cords were compared with
the regeneration stage when invasive meninges have produced
interstitial ECM and reactive ependymal cells grow out from
the central.
Figure 1A shows a trichrome stained histological cross-
section of intact adult lumbar region Axolotl spinal cord. The
normal meningeal layers were very thin and stain with aniline
blue, indicating the presence of collagen. A stereoscopic image
of a wholemount preparation of control cord was stained
with metanil yellow for collagen and alcian blue for acidic
proteoglycans (Figure 1B). The entire cord and the nerve
roots are ensheathed with the collagen-containing meninges
(Figure 1B). Small areas of alcian blue represent mainly
basal lamina associated with capillaries (Figure 1B). Following
transection, meningeal fibrosis produced a mass of interstitial
ECM seen here in an unstained stereoscopic wholemount
preparation (Figure 1C). The tapered regenerating outgrowth of
the cord was embedded in the meningeal matrix. In a parasagittal
paraffin section, the trichrome stain showed a large amount
of aniline blue-stained fibrillar collagen with cells interspersed
(purple) across the lesion site (Figure 1D). The violet material on
the right was associated with a fibrin clot.
One bulbous end of a 2-weeks regenerating cord showed
several features (Figure 1E). An extensive amount of alcian
blue-stained sulfated proteoglycan-containing ECM overlayed
metanil yellow-stained fibrillar collagen-containing ECM. This
meningeal investment of the regenerating cord stump showed
numerous dark orange cells on the ECM (arrows). This
appearance reflected the large amount of yellowish lipid seen
against the stained ECM. In regenerating spinal cord labeled
solely with alcian blue and dissected in a parasagittal plane, the
lipid-laden cells were found throughout the fibrotic ECM at the
tip of the regenerative outgrowth (Figure 1F).
Organic solvents used to embed material for sectioning
extracted most of lipid present in the lipid-laden cells like those
shown in Figures 1E,F, precluding lipid staining in paraffin
sections. However, DAPI nuclear label in a cross-section of
stump near the lesion site showed the presence of numerous
multinucleated cells in fibrotic meninges surrounding the spinal
cord in the regenerating tissue (Figures 1G,H).
To characterize the lipid-laden cells described in Figure 1,
regenerating cord was labeled with the lipophilic membrane stain
DiI and the fluorescent F-actin probe rhodamine-phalloidin.
Figure 2A shows a wholemount view of unstained spinal cord
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with outgrowth from one side of a transected, regenerating cord.
Dark melanocytes were present on stump meninges, as they are
on control cords. The dashed line shows the margin of injury-
reactive material accumulated near the cut end (Figure 2A).
A region of this regenerating outgrowth is shown in the DiI
wholemount stain that follows (Figure 2B). DiI/DAPI labeling
showed a region of lipid-containing cells concentrated in the
meninges, on the regenerative outgrowth (Figure 2B). These
lipid-laden cells were not present on the surface of the stump
distant from the transection (∼2 cm from the regenerating
end; Figure 2C). DiI staining of the distal stump showed only
the white matter axonal myelin just beneath the cord surface
(Figure 2C).
Rhodamine-phalloidin labeling for F-actin showed a small
group of MNGCs on the reactive meninges of another lesioned
cord (Figure 2D). The distinctive podosome actin dots of the
sealing ring were seen around the margin of the MNGCs, along
with regions of the more interior ruffled border (Figure 2D).
These structures were localized to the margins of spreadMNGCs,
like that shown in lesion site outgrowth in vitro (Figure 2E). The
outgrowth shown in Figure 2E was from a distal end region of
the regenerating cord like that shown in Figure 2A.
Fine-structural detail of ECM, ependymal cells, foam cells
and MNGCs in regenerating Axolotl cord was obtained by
transmission electron microscopy (TEM). A toluidine blue-
stained plastic thick section of a 2-weeks lesion site showed
an overview of a lesion site examined by TEM (Figure 3A). A
MNGC, in which nuclei were visualized through several sections,
is circled with a dashed yellow line. TEM examination of this
area showed juxtaposition of the MNGC, ependymal cells and
foam cells (Figure 3B, enlarged area Supplemental Figure 2).
At increased magnification, masses of vimentin intermediate
filaments were seen around one of the MNGC nuclei [Figure 3C;
(59)]. An enlargement of the zone of intermediate filaments is
shown in Supplemental Figure 2B. The dark structure next to
the MNGC appeared to be a telopode [Figure 3C; (60)].
Figure 3D shows a higher magnification view of an area
between foam cells and ependymal cells. A large amount of
fibrillar collagen was present and appeared to be in the process of
engulfment (Figure 3D). Figures 3E,F shows a foam cell among
meningeal cells, deeper in the lesion site. Fibrillar collagen was
absent from this zone. Other white blood cells are found within
the 2 weeks regenerate lesion site: Supplemental Figures 3A,B
show a macrophage engulfing red blood cells and a lymphocyte
among ependymal and meningeal cells (61, 62).
Later in the regeneration process ependymal outgrowth
re-epithelializes to reform the central canal, re-extend radial
processes, re-form endfeet and form channels through which
regenerating axons extend (2, 5, 10). Figure 4 shows the 4–5
weeks period of regeneration at which the regenerating ends
of the cord had met and axonal regrowth is underway to
restore the full thickness spinal cord. In Figure 4A, a trichrome-
stained paraffin cross-section of a 5 weeks regenerate lesion site
shows an asymmetrical regenerate with enlarged central canal.
The meninges were excluded to the periphery and were still
highly reactive, filling the entire space between the regenerating
cord and neural arch and vertebral body. Figure 4B shows a
higher magnification view of a section like Figure 4A. The
enlarged central canal contained extruded cellular material. The
collagenous denticulate ligament (arrow) was adjacent to the
regenerating cord. This is significant because the denticulate
ligament is an extension of the pia mater, and indicated pial
restoration around the regenerating cord. A toluidine-stained
plastic section showing a cross-section of a proximal stump
from a 4 weeks regenerating cord showed the reactive meninges
adjacent to the white matter (Figure 4C). This region contained
a denticulate ligament profile, comparable to Figures 4A,B. The
reactive meninges contained foamy cells and a variety of white
blood cells and meningeal cells (Figure 4C).
Ependymal and Foamy Macrophage Lipid
Content and Uptake
The presence of neutral and polar lipid in both ependymal cells
and foamy macrophages was shown by using Oil Red O stain
for neutral lipid, and DiI staining and DyRect, a proprietary
stain, for polar lipids. CD36 was identified as a significant lipid
transporter in these cells, in association with TLR4, through
antibody localization in vivo and in vitro and treatment with
a CD36 inhibitor in vitro. Exposure to DiI-labeled Ox-LDL
showed the capacity for additional uptake of Ox-LDL in vitro in
foamy macrophages.
Neutral and Polar Lipids
When 14D regenerating spinal cord outgrowth was placed in
culture, accumulation of small lipid droplets in phase contrast
images of live ependymal outgrowth, and a larger mass of
lipid in foamy macrophages can be clearly seen (Figure 5A).
The fluorescent lipophilic cationic indocarbocyanine dye, DiI,
is used here as a direct lipid probe. The amount of DiI stained
foamy macrophage lipid was greater, and lipid droplets generally
larger, than that in ependymal cells, but both cell types were
labeled (Figure 5B). To examine the presence of neutral lipids,
Oil Red O staining was performed. Oil Red O stains both
ependymal cells and foamy macrophages showing that some of
the lipid in both cell types was neutral lipid (Figures 5C,D).
At higher magnification both labeled and unlabeled lipid
droplets can be seen in foamy macrophages and ependymal cells
(Figures 5C,D insets).
Identification of the types of lipid labeled by DiI has never
been clear, beyond its known intercalation behavior into cell
membrane phospholipid layers (63).While this implies an affinity
for polar lipids, the targets are not certain. To further explore
polar lipid content, a proprietary polar lipid label was applied
to live cultures. Ependymal and foam cells both showed polar
lipid content (DyRect Kit; Figures 5E,F). The polar lipid label
showed strong overlap with the DiI staining, suggesting polar
lipid components were detected by DiI in our cells. In addition
to mononucleated foamy macrophages, small MNGCs with lipid
also stained strongly for polar lipids (Figure 5F). The Figure 5F
inset indicates the location of 4 nuclei. Nuclear counterstaining
was not possible because this was a live cell labeling process
and cells could not be permeabilized. The neutral lipid staining
properties of the DyRect reagent were not useable in the
Axolotl cells. The neutral lipid probe fluorescence overlapped too
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FIGURE 2 | Regenerating cord meninges MNGCs and foam cells. (A) Red dashed lines shows the region of regenerating outgrowth with lipid-laden cells in one side
of a 16D spinal cord regenerate. (B) Lesioned wholemount cord from 16D regenerating cord dual-labeled with DiI (red/lipid) and DAPI (blue/nuclei). Lipid-laden cells
are clustered near the regenerating end. White arrows show cells labeled with DiI and yellow arrows show labeled nuclei. (C) Image near the surface of 16D
wholemount distal stump of a regenerating cord labeled with DiI. White arrows show white matter in axonal tracts, while blue arrows indicate surface melanocytes. (D)
Regenerating 14D spinal cord wholemount labeled with rhodamine phalloidin (red/actin) and DAPI (blue/nuclei). Podosomes labeled with rhodamine phalloidin (yellow
arrows) can be seen surrounding the nuclei of MNGCs. The ruffled border is indicated by white arrows. (E) Phase contrast image of unlabeled outgrowth from a 14D
regenerate in culture 11 days. MNGCs were detected in the outgrowth (white arrows), in addition to foam cells (yellow arrows). Regen, regenerating; wm, white matter;
mel, melanocyte; MNGC, multinucleated giant cells; DIV, days in vitro. Magnification bar is shown in the lower portion of each image.
strongly with green autofluorescence and was of no utility (see
Supplemental Figure 4).
Lipid Transporters
The fatty acid translocase/lipid scavenger receptor CD36 is
the best candidate for lipid transport in the injured Axolotl
spinal cord based on foamy macrophage behavior in other
tissues (25). An antibody was identified that reacted with
CD36 in paraffin-embedded Axolotl tissue and in vitro.
In other sources of foam cells, TLR4 co-localizes with
CD36 and assists in the lipid transport process, so TLR4
localization was also examined (40). A combination of two
TLR4 antibodies to different TLR4 sites was identified that
reacts with strongly Axolotl cells in vitro, and was effective in
paraffin sections.
In intact adult Axolotl spinal cord sections, the lipid
scavenger receptor CD36 was seen in the ependymal
endfeet and in small zones of the ependymal cell bodies
(Figures 6A,B). In the proximal stump region of the lesioned
spinal cord, CD36 was expressed in the reactive meninges,
as well as the ependymal cells (Figures 6C,D). In vitro,
CD36 was strongly expressed by foamy macrophages and
small MNGCs (Figures 6E inset). Reactive ependymal
cells retained CD36 expression in vitro, as well (Figure 6F).
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FIGURE 3 | TEM showing close relationship between MNGC, ECM, ependymal cells, and foam cells. (A) Thick section of plastic embedded 2-weeks spinal cord
regenerate outgrowth stained with toluidine blue. Yellow dashed circle surrounds MNGC. (B) Thin section TEM of lesion site shown in (A). A portion of the MNGC is
circled in yellow (dashed line). Arrow indicates portion of the ruffled border. Foamy macrophages and ependymal cells are present. (C) A portion of the ruffled border,
and perinuclear intermediate filaments are shown. Engulfed myelin fragments are present within the cytoplasm. Engulfed myelin enlarged in inset (arrows) (D) Foamy
macrophage engulfing fibrillar collagen within the lesion site. Arrows show intracytoplasmic collagen. (E) Deeper within the lesion site a foamy macrophage is present
among ependymal and meningeal cells. (F) Deeper within the lesion site an ependymal cells show a network of processes (arrows). MNGC, multinucleated giant cells;
RB, ruffled border; RBC, red blood cell; Epen, ependymal cells; Ifs, intermediate filaments; Col, collagen; Mening, meningeal cell; macr, macrophage; Nucl, nucleus.
Magnification bar is shown in the lower portion of each image.
Localization of CD36 in foamy macrophages was, generally,
central/perinuclear and overlapped the zone of lipid droplets
(Figure 6E). CD36 was also present in ependymal cells
(Figure 6F).
TLR4 was expressed in both the foamy macrophages and
ependymal cells (Figures 6G,H). The region of TLR4 localization
in ependymal cells was comparable that seen for CD36
expression, but smaller that that seen in the foamy macrophages
(Figures 6F,H). TLR4 was not detected in large, lipid droplet-free
MNGCs (Figure 6G).
Ox-LDL Uptake in vitro
At the time of isolation, all lesion site foamy macrophages
and ependymal cells contained lipid acquired in situ and both
cell types expressed lipid transporters (Figures 5, 6). Results
shown in Figure 7 address the ability of foamy macrophages
Frontiers in Immunology | www.frontiersin.org 9 November 2019 | Volume 10 | Article 2558
Enos et al. Foam Cells in Spinal Cord Regeneration
FIGURE 4 | Later stage of the lesion site: rejoined cord. (A) Trichrome stained section through 5 weeks regenerate lesion site. Cord is asymmetrical, with enlarged
central canal, white matter not fully reconstructed. Extensive reactive meninges around the cord. Arrow: denticulate ligament. Collagen is blue. (B) Higher
magnification view of a trichrome stained section through the 5 weeks regenerate. Extruded material visible in central canal Arrow: denticulate ligament. (C) Toluidine
blue stained plastic thick section 4 weeks regenerate. Stump near lesion site. Reactive meninges with white blood cells and some foamy cells (red arrow), area of
denticulate ligament (yellow arrow). Magnification bar shown in the lower portion of each image. Dent Lig, denticulate ligament; Mening, meninges; Wk, week.
and reactive ependymal cells to take up additional lipid in
vitro. Explant cultures were established and exposed to DiI-
Ox-LDL. A subset of foamy macrophages took up significant
amounts of DiI-Ox-LDL (Figures 7A–E). High uptake foam
cells were found migrating on the plastic dish, as well as
on and under the explants (Figures 7A,B,D,E). The limited
number of MNGCs seen in these cultures did not take up
DiI-Ox-LDL (e.g., Figure 7A). Ependymal cells also did not
take up DiI-Ox-LDL in vitro (Figure 7B). All of the foamy
macrophages and ependymal cells contained extensive lipid
stores (Figures 7A–C), so it is not clear whether those not actively
transporting did so because they had reached maximum LDL
content, or whether the culture conditions were not fully optimal
for lipid uptake.
Functional involvement of CD36 in the in vitro Ox-
LDL uptake was shown by combining DiI-Ox-LDL uptake
with treatment using the CD36 inhibitor sulfo-N-succinimidyl
oleate, a modified fatty acid (64). Typical dense DiI-Ox-LDL
uptake label was seen in actively transporting control cultures
(Figure 8A). Co-treatment with the Ox-LDL label and the oleate
inhibitor reduced the area of uptake to small patches and
streaks (Figure 9B). This inhibition of Ox-LDL uptake shows a
functional role for CD36 in lipid uptake in the Axolotl spinal
meninges foam cells.
Myelin Uptake
Myelin fragments produced from damaged white matter
in urodele SCI are seen within lesion site cells in TEM
studies [Figure 2C; (5, 12)]. To determine whether the foamy
macrophages and/or ependymal cells were serving this function
in our experimental system, the presence of myelin engulfed in
situ (lesion site myelin uptake) was examined along with the
ability of lesion site cells to take up additional myelin in vitro.
To avoid the enormous amount of autofluorescence found
in Axolotl lesion site white matter, endogenous myelin content
was assayed by staining primary cultures with fluoromyelin red.
Fluoromyelin-labeling ofmyelin fragments taken upwhile in situ,
were seen in cells within the lesion site explants (Figure 9A),
in ependymal cells (Figures 9A,B) and foamy macrophages
migrating on the culture dishes (Figures 9B–D). In areas of
outgrowth showing large numbers of foam cells mixed with
ependymal cells, more myelin label appeared in the foam cells
(Figure 9B). Within a given culture there were areas of foam cells
with different amounts of myelin stain (Figures 9C,D).
The continuing ability of lesion site cells to take up myelin
fragments was also assayed in vitro. The probe was DiI-labeled
Axolotl brain myelin. New myelin uptake was seen by cells
within the explants (Figures 10A,E,F). In the cellular outgrowth,
some zones of ependymal cells showed extensive myelin uptake
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FIGURE 5 | Ependymal cells and foamy macrophages take up neutral and polarized lipids in regenerating spinal cord explants. (A) Lipid droplets were apparent
ependymal (white arrows) and foamy macrophages (yellow arrow) in unstained explant cultures of 14 days regenerating spinal cord. Phase contrast image (B)
Ependymal (white arrows) and foamy macrophages (yellow arrows) in regenerating explant cultures are labeled with polar lipid marker DiI. Fluorescence/Phase
contrast image. (C) Ependymal cell lipid droplets label with neutral lipid marker Oil Red O. Phase contrast image. (D) Foamy macrophages lipid droplets also label with
neutral lipid marker Oil Red O. Phase contrast image Insets in (C,D) show higher magnification images of ependymal cells and foamy cells, respectively. (E,F)
Ependymal cells (white arrows in E), foamy macrophages (yellow arrows in E,F), and MNGCs (white arrow in F) all labeled with a commercial polar lipid marker.
Fluorescence/Phase image, Inset in (F) shows a higher magnification of an MNGC with 4 nuclei, fluorescence only. Regen, regenerating; DIV, days in vitro.
Magnification bar is shown in the lower portion of each image.
(Figure 10A), while in others there was little (Figures 10C,D).
The regions with extensive ependymal myelin uptake appeared
to be free of foam cells, as in Figure 10A. Foamy macrophages
showed robust DiI-myelin uptake in vitro (Figures 10B–D). A 2-
days period of exposure was used for the labeled myelin uptake.
Cells were cultured without DiI-myelin for an additional 12 days,
during which the ependymal cells appeared to turn over most
of the labeled myelin (Figure 10A compared with Figure 10E).
During the 12 days chase period foamy macrophages seemed to
retain more of the labeled myelin, or turnover had released free
DiI in these cells which partitioned into lipids stored within the
cells (Figure 10F).
Frontiers in Immunology | www.frontiersin.org 11 November 2019 | Volume 10 | Article 2558
Enos et al. Foam Cells in Spinal Cord Regeneration
FIGURE 6 | CD36 and TLR4 in regenerating cord in vivo and in vitro. (A) The scavenger receptor CD36 was detected on the endfeet of ependymal cells in control
cord paraffin cross-sections. Fluorescence image. (B) CD 36 is also present on ependymal cell bodies in intact adult Axolotl spinal cord. Fluorescence image. (C) In
paraffin sections from regenerating cord stump CD36 was detected in ependymal endfeet in the reactive meninges. Fluorescence image. (D) CD36 also present on
ependymal cell bodies in regenerating cord, proximal stump. Fluorescence image. (E) In vitro, CD36 is found on foamy macrophages from 10D regenerate spinal
cords 6 days in vitro (yellow arrows). Orange arrows show three nuclei in CD36+ MNGC. Inset in (E) shows a CD36+ MNGC with six nuclei. (F) CD36+ Ependymal
cells (white arrows) in explant cultures from a 10D regenerate spinal cord 6 days in vitro. (G) TLR4 was detected in foamy macrophages (yellow arrows) in culture on
cells from 14 days regenenerates, 17 days in vitro. (H) Ependymal cells from 14 days regenenerates, 17 days in vitro are also TLR4+ (white arrows). D, day; Regen,
regenerating; MNGC, multinucleated giant cells; TLR4, toll like receptor 4. Magnification bar is shown in the lower portion of each image.
Cathepsin K
The cysteine protease cathepsin K catabolizes several ECM
molecules, including collagen, elastin, and gelatin. We
hypothesized that cathepsin K present in Axolotl cells within the
regenerating cord might be involved in catabolizing the fibrous
collagen in the lesion site, allowing the regenerating cells to form
Frontiers in Immunology | www.frontiersin.org 12 November 2019 | Volume 10 | Article 2558
Enos et al. Foam Cells in Spinal Cord Regeneration
FIGURE 7 | A subpopulation of foamy macrophages takes up DiI-labeled oxidized low-density lipoprotein receptor. Seventeen days cord regenerates were cultured
for 11 days in vitro (A,B) or 17 days in vitro (C–E) and were treated with DiI-Ox-LDL for 4 days (A,B) or 6 days in vitro (C–E). MNGCs and ependymal cells (white
arrows) were not labeled; however, a subpopulation of foamy macrophages (yellow arrows) were labeled. (C,D) Are the same field, with the explant shown in phase
contrast in (C) and overlaid with fluorescence to highlight the foamy macrophages that have taken up DiI-Ox-LDL (yellow arrows). (E) Shows foamy macrophages that
have migrated out of the explants and taken up DiI-Ox-LDL in culture. D, day; Regen, regeneration. Magnification bar is shown in the upper portion of images A and E,
and the lower portion of images (B–D).
a more regeneration-friendly region in which new ECM might
be secreted. To determine if cathepsin K was expressed in the
lesion site, cells in vivo and in vitro were labeled with cathepsin
K antibody. Figure 11A shows a reactive meningeal flatmount
from the lesion site where cells were labeled with cathepsin
K antibody. In culture, there was expression of the enzyme
in cells within the explants and in foamy macrophages and
ependymal cells growing out of the explants (Figures 11B–E). In
favorably oriented foamy macrophages, the cathepsin K was seen
concentrated between the foam cell and the plastic substratum
within the sealing ring (Figures 11B,C). In migrating ependymal
cells, substantial portions of the cytoplasm were cathepsin
K-positive (Figures 11D,E). Small MNGCs also expressed
cathepsin K (Figure 11E).
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FIGURE 8 | CD36 inhibition reduces DiI-Ox-LDL uptake by foamy macrophages. Seventeen days regenerate spinal cord regenerate explants, were treated with
DiI-Ox-LDL at 10DIV for 24 h as the control (A) or with the CD36 inhibitor sulfo-N-succinimidyl oleate added at 10DIV plus DiI-Ox-LDL added at 11DIV for 24 h. (B)
Inhibitor-treated explants showed less uptake of DiI-Ox-LDL in comparison to control. D, day; DIV, days in vitro; Ox-LDL, oxidized low-density receptor; inhib, inhibitor;
Regen, regeneration. Magnification bar is shown in the lower portion of each image.
Glycosaminoglycan Synthesis
Both foam cells and ependymal cell produce ECM-degrading
enzymes [Figure 11; (20)], but ependymal cells also rebuild the
regenerating spinal cord, including reforming the basal lamina of
the glia limitans (10). Comparison of the ECM synthetic capacity
of foamy macrophages and ependymal cells was performed
using 3H-glucosamine incorporation and autoradiography as
an assessment of glycosaminoglycan and proteoglycan synthetic
capacity (65).
Extensive 3H-glucosamine uptake by mesenchymal
ependymal cells occurred over a 24-h incubation in established
cultures (Figures 12A,C). Label occurs in the cytoplasm and
nucleus, and there is deposition of material onto the substrate
near the explants where ependymal cells were most densely
distributed. The nuclear label is associated with nuclear pore
complex incorporation of O-linked N-acetyl glucosamine
synthesized from the 3H-glucosamine (66). No incorporation
of 3H-glucosamine was seen in or around any of the foamy
macrophages, identified on the basis of their lipid droplet
content comparable to those cells labeled with Oil Red O
and DiI (Figures 5, 12B,C). This indicates a major difference
in lesion-site remodeling roles between ependymal cells and
foamy macrophages.
Foam Cell/Ependymal Interaction
To observe foam cell interaction with the ependymal cells,
regenerating tissue was placed in culture conditions that
maintain mesenchymal ependymal outgrowth and proliferation
of reactive Axolotl spinal cord ependymal cells (56). Pieces
of tissue with reactive meninges and ependymal cells grown
in culture typically showed three stages of growth: (1) at
3 h after the start of culture, the attachment period, the
explant was firmly adherent and cells at the margins started
to extend processes (Figure 13A), (2) after 1 day of culture
(Figure 6B), injury-reactive ependymal cells were migrating
out of the explants and meningeal tissue was spreading,
and (3) at 4 days in culture, the explants had extensive,
dispersed ependymal outgrowth with foamy macrophages
on and among the ependymal cells (Figure 13C). The
extensive outgrowth period persists though at least 22 days
in vitro.
Labeling of cultured 2-weeks regenerating spinal cord with
fluorescent-phalloidin showed localization of F-actin in sealing
rings of foamy macrophages on the ependymal outgrowth
(Figure 13D). At 4 weeks of regeneration, the ependymal
outgrowth was reconnected between the cranial and caudal
stumps (10). When 4-weeks lesion site regenerate tissue was
excised and cultured, the foam cells were no longer localized with
the ependymal cells (Figure 13E).
In analysis of cellular arrangement in culture, outgrowth
could be divided into 5 forms of foamy macrophage/ependymal
interaction: (1) condensed outgrowth with no foamy
macrophages (Figure 14A), (2) condensed outgrowth with
foamy macrophages (Figure 14B), (3) dispersed outgrowth with
foamy macrophages (Figure 14C), (4) dispersed outgrowth
without foamy macrophages (Figure 14D), and (5) mixed
(Figure 14E). Ninety-two photographic fields from >16 explants
in 7 experiments were sorted into the categories listed above. A
one-way analysis of variance (ANOVA) with a post-hoc Tukey
analysis showed a highly statistically significant difference
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FIGURE 9 | Endogenous myelin uptake is robust in ependymal cells and foamy macrophages. Fourteen days regenerate spinal cord explants were cultured for 8 days
in vitro and stained with fluoromyelin label to reveal endogenous myelin uptake from the lesion site. Fluorescence/phase images. (A) The explant periphery is heavily
labeled as is a zone of ependymal outgrowth (white arrows). There are a few, scattered myelin-containing foam cells (yellow arrows). (B) In a mixed zone of outgrowth
foam cells are labeled (yellow arrows), but ependymal cells show little label (white arrows). (C) A zone with heavily myelin-laden foam cells (yellow arrows). White arrow
shows one myelin-laden ependymal cell. (D) A zone of foam cells with little endogenous myelin uptake (yellow arrows). Endog, endogenous; Epend, ependymal.
Magnification bar is shown in the lower portion of each image. Magnification bars are in the lower portion of images.
between the presence of foamy cells with dispersed vs. condensed
ependymal cells (Figure 14F). The occurrence of dispersed
ependymal growth with foamy macrophages was far more
prevalent when compared to the dispersed ependymal cells
without foamy macrophages. This difference is highly significant
with a p-value < 0.0001. Conversely, a condensed form of
reactive ependymal cell outgrowth occurs in the absence of foam
cells, compared to the occurrence of condensed outgrowth in the
presence of foam cells (p-value < 0.0001). Further test details are
included in Supplemental Figure 5.
DISCUSSION
Diagrammatic Summary
The cell and ECM associations shown in Figures 1–3 are
interpreted diagrammatically in Figure 15A. Fibrillar collagen
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FIGURE 10 | In vitro uptake and turnover of myelin in ependymal cells and foamy macrophages. Fourteen days regenerating cord explants were cultured for 8 days,
then incubated with DiI-labeled Axolotl brain myelin for an additional 2 days. A representative combination of outgrowth and explants labeling images are shown. (A) In
a region with ependymal cell outgrowth only, the explants and ependymal outgrowth took up significal levels of labeled myelin fragments (white arrows). (B) In an area
of mixed, dispersed foam cell and ependymal cell outgrowth, only the foam cells are heavily labeled. (C) An denser area of dispersing ependymal cells (white arrows)
plus foam cells (yellow arrows) shows heavy myelin uptake in vitro only in the foam cells. (D) A sparsely labeled explants has strongly labeled foam cell outgrowth
(yellow arrows) and unlabeled ependymal cells (white arrows). (E,F) Show a 12 days myelin-free chase period following 2 days of DiI-Axolotl-myelin uptake. (E) Shows
part of the same region shown in (A). Labeled myelin in the ependymal outgrowth is greatly reduced (white arrows). The explants is still labeled. (F) Even after the 12
days chase period, foam cells. D, day; Epend, ependymal; FC, foam cell. Magnification bar is shown in the lower portion of each image.
from the meninges was found throughout the lesion site
between the retracted spinal cord stumps after transection.
Sulfated proteoglycan was found throughout the outgrowth,
but concentrated closer to periphery. Meningeal cells invaded
from the periphery while reactive ependymal cells withdrew
their radial processes, became mesenchymal and migrated out
into the lesion site (16). Macrophages and foamy macrophages
were present.
Figure 15B shows a composite model of markers to be
used throughout the experimental results, illustrating foam cell
specializations that were characteristic to this cell type and are
indicators of function within the Axolotl cord lesion site. On
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FIGURE 11 | Cysteine protease cathepsin K was detected in meninges, ependymal cells, foamy macrophages, and MNGCs in vitro and in vivo. (A) Wholemount cord
tissue from 16D regenerating cord were co-labeled for cathepsin K (red) and DAPI (blue). Cells on the surface of the meninges are positive for cathepsin K (dashed
white line). Explants from 16D regenerate cord, cultured for 10DIV, showed labeled ependymal cells (B,D,E), foamy macrophages (B, dashed square), and an MNGC
(E). Yellow arrows indicate foam cells, white arrows indicate ependymal cells. Ruffled borders sequestering cathepsin K between foam cells and the culture
substratum were also detected (yellow arrow, C). Yellow arrows indicate nuclei in MNGCs positive for cathepsin K in (E). Regen, regenerating; D, day; DIV, days in
vitro; MNGC, multinucleated giant cells. Magnification bar is shown in the lower portion of the images.
the unattached cell surface, is the lipid transporter CD36 which
would mediate uptake of lipids, to be sequestered within the
cytoplasm. TLR4/TLR6 acts in concert with CD36 in transport
and are also known to be involved in fusion into MNGCs (23).
The sealing ring structures and cathepsin K are show on and
associated with the ECM-attached surface.
Organization of the Lesion Site
There are species differences in urodele SCI responses, just
as there are in rodents (10, 67). The ependymal outgrowth
process during gap regeneration in newts is more in the form
of an epithelioid bulb than mesenchymal outgrowth, but newt
transection lesion sites share features with those seen here
in the Axolotl (5, 12, 16, 68). In early stages of spinal cord
regeneration in both Notophthalmus viridescens (Eastern Red-
Spotted Newt) and Ambystoma mexicanum (Axolotl) a fibrillar
collagen-rich ECM wraps the regenerating tissue (Zukor et al.,
Figure 7; our Figure 1E). In the Axolotl, fibrillar collagen-
containing matrix encases and bridges the cut ends of the cord,
and cells grow out into that material (Figures 1C,D). Zukor et al.
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FIGURE 12 | Ependymal cells in cord explant cultures synthesize ECM components. Synthesis of glycosaminoglycan and proteoglycan was investigated by
incubating explants with 3H-glucosamine and performing culture dish autoradiography. (A) Silver grains were detected in the ependymal cell nuclei (red arrows) and
cytoplasm (yellow arrows). (B) No silver grains were deposited on or around the foamy macrophages. Yellow arrows indicate foamy macrophage nuclei. (C) Lesion
site explants is heavily labeled with silver grains. Patches of unlabeled foamy macrophages are found within the explants (yellow arrows) and beyond the ependymal
cells (white arrows). 3H, tritiated; GlcN, glucosamine; Autorad, autoradiography. Magnification bars are shown in the lower portion of the images.
(12) showed the accumulation of CSPG in the meninges after
transection in the newt. The Axolotl ECM that supported foam
cell, MNGC and ependymal cell invasion also contained sulfated
proteoglycans (Figures 1E,F). In both the newt and Axolotl there
is little sulfated proteoglycan present before injury (Figure 1B).
Compared to mammalian SCI ECM, it still not entirely clear
whether the interstitial matrix that forms with meningeal fibrosis
in urodeles is intrinsically non-inhibitory in composition or
organization, or whether regeneration proceeds because of
successful removal of this material (69–71). Production of
cathepsin K by the foamy macrophages, MMP and cathepsin
production by ependymal cells, plus known MMP production
by foamy macrophages in other tissues suggests that removal of
the ECM material is likely a strong component of the process
[Figure 11; (20, 72)].
Axolotl lesion site ECM appeared to have two zones:
one closely wrapped around the regenerating cranial
and caudal ends of the cord plus the material between
the cut ends. Following fixation, they were separable,
the wrapped material remained firmly attached to the
regenerating cord (Figures 1C,E,F). Inflammatory response
cells accumulate in this material in both the newt and Axolotl
[(12); Figures 1–4; Supplemental Figure 2]. Though not
explicitly identified, the newt TEM images shows lipid-laden
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FIGURE 13 | Stages of migration of ependymal and foam cells from lesion site explants in vitro. Phase images of a 10D regenerating cord explant showing three
different stages of cellular outgrowth; (A) at 3 h after the beginning of culture, the explant was firmly attached to the fibronectin-coated dishes and cellular processes
begin to extend away from the edges of the explant (B), after 1D in vitro (1DIV), ependymal cells are migrating out of explants, while meningeal tissue is spreading, (C)
after 4DIV, there is extensive dispersed ependymal outgrowth as well as foamy macrophages on and among the ependymal cells (D). Rhodamine-phalloidin label of a
cultured 2 weeks regenerating cord (red) showed the sealing ring of a foamy macrophage (FC arrow). (E) Cultured 4 weeks regenerates showed no foamy cells
attached to ependymal cells. Regen, regenerating; hrs, hours; D, day; DIV, days in vitro; mening, meningeal cells; Epend, ependymal cells; Rh-Phall,
rhodamine-phalloidin. Magnification bar is shown in the lower portion of each image.
cells among the immune response cells accumulated in
the reactive meninges (12). In the Axolotl lesion site,
the foamy macrophages were concentrated in and on
the meninges of the regenerating cranial and caudal stumps
(Figures 1, 2).
In situ, MNGCs are found in clusters on and in the
fibrotic meninges (Figures 1G,H, 2D, 3A–C). It is not known if
representative numbers of these cells are growing out of the lesion
site explants in vitro, or whether they are so strongly attached
to lesion site ECM that they are under-represented on the
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FIGURE 14 | Five types of cellular interactions between ependymal cells and foam cells in cultured regenerative outgrowth. Cultures in which foam cells were
associated with condensed or dispersed ependymal cells from 14 to 17D spinal cord outgrowths were quantitated. Dispersed ependymal cells show a preference for
associating with foam cells: (C) As opposed to condensed ependymal cells (A,B) or mixed condensed and dispersed ependymal cells (E). (D) Shows a limited region
of dispersed ependymal cells without foam cells. (F) Shows a graph depicting the quantitation of cultures. Cond, condensed; disp, dispersed. ***p ≤ 0.0001.
Magnification bar is shown in the lower portion of each image.
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FIGURE 15 | Diagram of ECM and cellular associations in regenerating cord. (A) Diagrammatic representation of mesenchymal ependymal cell outgrowth and
meningeal invasion gap regeneration of the Axolotl cord lesion site. Ependymal cells, foam cells, MNGCs, macrophages and meningeal cells are shown within
extracellular matrix. Neurons and oligodendrocytes are not represented. (B) Diagrammatic representation of a foamy macrophage producing cathepsin K.
culture dish. Cluster of MNGCs are not seen in the culture dish
outgrowth (Supplemental Figure 6). Further studies of axolotl
meningeal MNGC formation and behavior are required.
Identification of Ependymal Cells
In these culture conditions (+EGF, fibronectin coating),
the cells that grow out of the lesion site explants are
ependymal cells, foamy macrophages, MNGCs and, rarely,
melanocytes [Figures 2E, 5–11, 13; Supplemental Figure 7; (6,
16, 56, 73)]. Other cord or meningeal cells fail to exit the
explants. The Axolotl ependymal cells have been thoroughly
characterized in prior marker studies. Intact Axolotl cord
ependymal cells are cytokeratin and glial fibrillary acidic
protein (GFAP)-positive and the cytokeratins and GFAP are
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lost during epithelial-mesenchymal transition (6, 16, 73). All
of the injury-reactive Axolotl ependymal cells express the
stem/progenitor cell marker mRNA-binding protein Musashi1
(16). A Musashi1 expression image is shown, again, at reviewer
request along with GFAP intermediate filaments in the process
of turnover. The appearance of the large ependymal nuclei
is also quite distinctive (56). Examples of control culture
Musashi1 localization and perinuclear GFAP in vitro are shown
in Supplemental Figure 8.
Identification of Axolotl Foamy
Macrophages
The identification of the lipid-laden mononucleated cells in the
Axolotl lesion site in situ and in vitro as foamy macrophages
was based on systematic examination of markers used in
mammalian foamy macrophages. The labeling of lipid droplets
with Oil Red O was primarily perinuclear (Figure 5), as it
was in mammalian foamy macrophages (29). The cells also
took up DiI-Ox-LDL like mammalian foam cells [Figure 7;
(28, 74)]. The lipid transporters localized in the Axolotl foamy
macrophages were CD36 and TLR4, the primary transporter
and co-transporter used by mammalian foamy macrophages
[Figure 6; (75)]. An active role for CD36 in lipid transport
was supported by the specific inhibition of Ox-LDL uptake by
the modified fatty acid Sulfo-N-succinimidyl Oleate [Figure 8;
(64)]. Axolotl spinal cord foamy macrophages took up myelin
fragments in vivo and in vitro, like foam cells in diseases
including multiple sclerosis, and within mammalian spinal cord
after SCI [Figures 2C, 9, 10; (27, 34)]. Myelin uptake by
macrophages in mammalian SCI and multiple sclerosis models
is a phagocytic process, and membrane-bound myelin inclusions
are seen in our foamy macrophages and smaller MNGCs by
TEM [(41, 76); Figure 3C inset]. Axolotl foamy macrophages
produced cysteine proteinase cathepsin K characteristic of
mammalian foam cells, and cathepsin Kwas seen localized within
sealing rings [Figure 11; (54)]. Finally, TEM examination shows
ultrastructural features like a ruffled border and perinuclear
intermediate filaments seen in mammalian foamy macrophages
[Figures 3B,C; Supplemental Figure 2; (59)].
Misidentification of Axolotl Foamy
Macrophages
Macrophages have been described in injured salamander spinal
cord, but not foamy macrophages (36). Results presented here
(Figures 1B, 2C) showed that foamy macrophages were absent
from distal stump and control Axolotl cord but accumulated
in the fibrotic meninges within 1–1.5mm on each side of the
transection site. There is a history of noting, but not accurately
identifying, these cells in the urodele regeneration literature.
Our early studies show the presence of lipid-laden mono- and
multinucleated cells in reactive axolotl cord ependymal cultures
that were considered to be osteoclasts and their precursors
that had migrated from neural arch following laminectomy
performed to expose the cord for transection (56). Maier and
Miller (77) noted the presence of what appear to be foamy
macrophages among newt limb blastema cells in culture, but
called them signet cells because they had eccentrically positioned
nuclei. Washabaugh and Tsonis (78) identified these cells as
signet cells following Maier and Miller [(78), Figure 1B] in
regenerating newt limb blastema cultures, noting the presence of
granules that appear to be lipid droplets. In a newt spinal cord
regeneration study, Zukor et al. (12) showed macrophages and
other white blood cells in and around the newt spinal cord lesion
site by TEM, and some of these appear to have foamy cytoplasm
[(12), Figures 7C,D]. The present studies are the first to show
that these lipid-laden cells concentrate in and on the meninges
at the lesion site in urodele spinal cord regeneration and to
characterize them as foamy macrophages based on functional
markers, lipid labeling and uptake studies.
Possible Source of Foamy Macrophages
Two waves of macrophage recruitment have been described in
mammalian SCI: first M1 (pro-inflammatory) macrophages of
splenic origin, then M2 (anti-inflammatory) macrophages from
either bone marrow or resident tissue immune cells (79). In a
mouse spinal cord contusion system, M1 macrophages precursor
cells were carried in the vasculature of the leptomeninges (mainly
the arachnoid layer), which exit through the subarachnoid space
to become M1 macrophages within the cord (80). Precursors
to the M2 macrophages enter the brain ventricular-choroid
plexus, travel through the cerebrospinal fluid, then invade the
injured spinal cord and became M2 macrophages (80). It appears
that conversion to mammalian cord foamy macrophages occurs
within the spinal cord tissue (34, 35). Control Axolotl cord and
stump tissue meninges have no foam cells (Figures 1B, 2C), but
they are abundant in the lesion site. The source of these foamy
macrophages and MNGCs is not yet known. Future studies
will be required to determine whether the entire population
is recruited from circulating monocytes and macrophages or
if resident macrophages proliferate locally and invade the
lesion site.
Multinucleated Giant Cells
Activity differs between large and smaller MNGCs in our
tissue culture system: smaller MNGCs and mononucleated
foamy macrophages were more like each other than were large
and small MNGCs. Cathepsin K activity, expression of the
lipid transporter CD36 and co-transporter TLR4 were found
in mononucleated foam cells and small MNGCs (≤6 nuclei,
Figures 6E,G, 11E). TLR4 was absent from very large MNGCs
(Figure 6G), consistent with the absence of lipid droplets. Very
largeMNGCs were generally lipid droplet free: one with 36 nuclei
is shown in Figure 6G and Supplemental Figure 6D along with
other non-lipid-containing MNGCs (Supplemental Figure 6),
so their origin or metabolic state may be very different from the
smaller lipid-laden MNGCs. Small MNGCs displayed cathepsin
K activity (Figure 11E), but large MNGCs were not seen in any
of the cathepsin K antibody labeled cultures, so the relationship
of large numbers of nuclei and ECM proteolysis is not yet known
in our system.
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Cytoskeleton Identity and Function
F-actin localization showed that the foamy macrophages
(Figure 13D) and MNGCs (Figure 2D) attach to the reactive
meninges with characteristic podosome-studded sealing rings.
These integrin and actin-containing structures are present in
other types of macrophages and osteoclasts, where they are
associated with a polarized (substratum-attached vs. free surface)
morphology needed for normal secretory and transport functions
(24, 32).
TEM studies show Axolotl meningeal foamy macrophages
and MNGCs with masses of perinuclear intermediate filaments
(Figure 3C; Supplemental Figure 2B). Vimentin intermediate
filament accumulation is characteristic of mononucleated
osteoclast precursors, osteoclasts and osteoclast-like MNGCs in
mammals and clustering of nuclei in MNGCs occurs within a
netlike “nest” of vimentin intermediate filaments (59).
Cathepsin K in vivo and in vitro
The cysteine protease cathepsin K is probably best known
for its role in osteoclast pit production on bone (24, 32).
Cathepsin K also performs a role in foamy macrophage and
macrophage-derived MNGC ECM degradation (32, 52–55).
Foamymacrophages in the Axolotl spinal cord lesion site showed
cathepsin K localization (Figure 11A) and, in vitro, foamy
macrophages and small MNGCs were all cathepsin K positive
(Figures 11B,C,E). In vitro, cathepsin K was localized within the
sealing ring between the cell and culture substrate and also within
the cytoplasm of foamy macrophages (Figures 11B,C,E).
In the normal CNS, cathepsin K is expressed inmouse choroid
plexus ependymal cells, but it is not a universal feature of intact
ependymal cells throughout the mouse CNS (81). It is not known
how widely distributed cathepsin K might be in the urodele CNS.
The activation of cathepsins is a complex process. Association
of cathepsins with negatively charged glycosaminoglycan
chains of proteoglycans allows autocatalytic activation (82). In
regenerating urodele spinal cord there is abundant sulfated
proteoglycan, including CSPG [Figure 1; (12)]. CSPG,
specifically, has been shown to be involved in extracellular
autoprocessing of pro-cathepsin K in osteoclasts (83), and is a
good candidate for the same role in reactive Axolotl ependymal
cells, foamy macrophages and MNGCs. This response to
the fibrotic meningeal sulfated proteoglycan would mediate
matrix degrading activity locally, contributing to prevention of
permanent scar formation.
Intracellular Distribution of Cathepsin K
Ependymal cell cathepsin K localization was markedly
asymmetrical (Figures 11B,D,E) and could be related to
leading edge/trailing edge polarity. In studies of tumor cells,
related to understanding metastatic migration, attempts have
been made to assign cathepsin localization to the leading edge or
trailing edge of migrating cells. In stationary breast carcinoma
cells, the localization of cathepsin B is perinuclear, but it is
concentrated on one side of the nucleus in a moving cell (84).
It is reported that this is the trailing edge of the cell (84). In a
study of cathepsin H localization in a prostate cancer cell line,
the cathepsin co-localizes with talin, a leading-edge protein
associated with focal adhesions in cell migration (85). The
cathepsin H was also abundant around the nuclei. The Jevnikar
et al. (85) paper is the only one showing a leading edge or trailing
edge marker (talin) co-localized with a cathepsin.
In our cultured foamy macrophages and MNGCs, the
cathepsin K was localized either within the sealing ring
(Figures 11B,C) or in a polarized fashion in elongated cells
(Figures 11B,E). In primary T-lymphocytes and T-lymphocyte
lines, cathepsin X is found strongly localized in the both the
leading edge and in the uropod, the trailing, deadhesive structure
of lymphocytes (86).
While associated with leading edge/trailing edge polarity
morphologically, correlation of cathepsin localization with a
mechanism of directional cell migration is not possible at this
time in either the ependymal cells or foamy macrophages.
Lipid in Ependymal Cells and Foamy
Macrophages
TEM examination has shown that normal urodele ependymal
cells contain some small lipid droplets. During regeneration,
newt tail cord TEM examination shows the accumulation of
lipid droplets in ependymal cells (2). The cytoplasm of intact
mammalian ependymal cells label with DiI, but the magnification
and resolution of the published images in that study do not
permit identification of lipid droplets (87). In other mammalian
studies, normal, young, non-pathological CNS ependymal cells
do not contain stores of lipid. In the ventral portion of the
brain, lateral ventricles of young mice stained with Oil Red O
shows little lipid in the ependymal cells (88). There is more lipid
in middle-aged mice and a high level of lipid in aged mouse
ependymal cells (88). Similarly, there is a large increase of lipid
in Alzheimer’s Disease choroid plexus ependymal cells connected
to expression of receptors for the transcytosis of LDL, lipoprotein
receptor-related proteins-1 and 2 (megalin) (89, 90). So lipid
accumulation in ependymal cells is associated with a disturbed
or pathological state in ependymal cells.
The combined Oil Red O, DiI and DyRect labeling
showed both neutral lipid and polar lipid content in both
ependymal cells and foamy macrophages (Figure 5). The Axolotl
ependymal cells and foamy macrophages also expressed the
lipid scavenger receptor CD36 in vivo and in vitro indicating a
common mechanism of lipid uptake (Figure 6). Therefore, both
ependymal cells and foamy macrophages could be participating
in removal of toxic lipids released or formed after neural injury.
The source of neutral and polar lipids in both populations of
cells could involve uptake of native and oxidized lipoproteins as
well as myelin breakdown products from the Axolotl spinal cord
lesion site.
Autofluorescence
Autofluorescence in Axolotl foamy macrophages confounds
the use of green fluorochromes, including the Dyrect neutral
lipid fluorochrome (Supplemental Figure 4). The source is
not necessarily unique, but foamy macrophages can take
up lipofuscin (ceroids) in pathological conditions (Dvorak
and Monahan-Early, 1992). Foam cells exposed to Ox-LDL
accumulate lipofuscin, and lipofuscin autofluorescence has even
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been used as a marker for phagocytic CNS macrophages
(74, 91). Lipofuscin can also be liberated by neuronal death.
Autofluorescence of lipofuscin has an emission spectrum in
the region of 430–490 nm, with a maximum in the yellow
range (92). This would bleed through typical green fluorescence
filters. The degree of autofluorescence of foamy macrophages
and ependymal cells varies, suggesting differential uptake of
autofluorescent compounds or differential exposure to them
within the lesion site. Maier and Miller (77) noted the
autofluorescence of what they termed “signet cells” from
regenerating newt limb blastemas.
Myelin Uptake
The myelin uptake behavior seen in the present study
could be beneficial in regeneration. The axolotl form of the
myelin-associated inhibitory molecules Nogo-A (axNogo), the
Nogo receptor and myelin associated glycoprotein (MAG) are
expressed in the Axolotl CNS, including during regeneration,
suggesting that they are not inhibitory. Localization of axNogo
and MAG in urodeles is primarily in gray matter neurons and
ependymal cells, unlike the myelin/oligodendrocyte localization
in mammals (93, 94). Despite these differences in the effects
of myelin-associated molecules between mammals and urodeles,
lesion site myelin was removed by ependymal cells and foamy
macrophages during activity in vivo and in vitro (Figures 9, 10).
One additional consideration regarding removal of myelin is
the role this process plays in modulating M1 pro-inflammatory
to M2 anti-infammatory phenotype of foamy macrophages
in multiple sclerosis models (22, 27, 34, 95–97). Pro- or
anti-inflammatory properties of Axolotl spinal cord foamy
macrophages remain to be studied.
There were distinct differences in initial myelin content in
ependymal cells placed in culture: some regions of explants
outgrowth labeled heavily and some not at all. This could be
dependent on their initial location within the lesion site. The
foamy macrophages are concentrated around the regenerating
ends of the cord, while the ependymal cells are growing out into
this zone from the spinal cord stumps. In regions close to the
transection site, the foamy macrophages may be the initial cell
population to engulf myelin fragments, outcompeting the later-
arriving ependymal cells. Deeper within the lesion site, where
there are fewer foamy macrophages (Figures 2A,B), ependymal
cells may be the primary cells to take up myelin.
Are Some Cells “Full” of Ox-LDLIn Culture?
Lipid droplets are themost visible form of cellular lipid storage. A
mature lipid droplet is described as a mass of neutral lipid within
a single phospholipid leaflet membrane (98). Lipid droplets have
a complex genesis and breakdown process within cells. Neutral
lipids are generated enzymatically in the ER and can be trafficked
to many parts of the cell including and the nucleus, lysosomes
and vacuoles. Intracellular storage of lipids reflects a balance
between uptake, consumption, interconversion of lipid forms
and release (98, 99). Cellular stress and immune factors play
significant roles in lipid balance (99).
The mechanisms underlying lipid balance in macrophages
have been studied most extensively in non-neural diseases, such
as atherosclerosis, non-alcoholic fatty liver disease (NAFLD) and
pulmonary alveolar proteinosis (PAP), including the conversion
of high levels of LDL to Ox-LDL related to foamy macrophage
formation and function (29, 100). Ox-LDLs are not recognized
by a macrophage’s native LDL receptor, but they are recognized
by the CD36 scavenger receptor (29, 75). Lipid uptake via
scavenger receptors is not subject to feedback regulation and
can lead to excessive accumulation of lipids in affected cells
(75, 90, 101). Cholesterol esters are hydrolyzed enzymatically
into free cholesterol, which can be utilized by cellular processes,
exported from the cell, or converted back to cholesterol esters
to prevent toxic effects from excess free cholesterol. Export of
high-density lipoprotein is the primary means of lipid efflux from
cells under normal conditions, though there is some passive free
cholesterol efflux (29, 100).
Cholesterol ester hydrolysis may be actively inhibited by Ox-
LDLs after prolonged exposure (102, 103). Exposure to Ox-
LDLs can lead to lysosomal accumulation of lipids, rather than
cytosolic accumulation of lipid droplets (102–104). However,
there are species-specific differences in Ox-LDL response:
free cholesterol and cholesterol esters were present in pigeon
macrophage lysosomes after Ox-LDL exposure, while lipid
accumulation was cytosolic in mouse macrophages (103).
Lysosomal dysfunction caused by Ox-LDLs may not be easily
reversed, which could explain why some of our foam cells don’t
take up much additional Ox-LDL in vitro (Figure 7). Other
modified LDLs can be metabolized without adversely affecting
essential lysosomal acidity and our foam cells are likely taking
up many types of modified LDLs, but those with a high existing
Ox-LDL burden would be inactive in the DiI-Ox-LDL uptake
experiments (105, 106). Prolonged lysosomal dysfunction could
be why our foam cells remain so full of lipid long after removal
from the injury site. The absence of DiI-Ox-LDL uptake in
ependymal cells in vitro (Figures 7A,B, 8A) could reflect natural
uptake of less oxidized forms of LDL in vivo, or a greater tendency
toward lysosomal dysfunction.
ECM Degradation vs. Synthesis
ECM Degradation
Cells migrate into the Axolotl cord lesion site through a collagen-
and proteoglycan-rich ECM (Figures 1D–F). The regenerating
cord shows a massive increase in the amount of ECM investing
the cord, compared with the normal cord meningeal ECM,
with a disproportional increase in sulfated proteoglycan content
(Figures 1B,E).
ECM is known to be phagocytosed and degraded
intracellularly by a variety of amphibian cell types, including
anuran (frog and toad) macrophages during the ECM
turnover associated with metamorphosis (107). TEM studies,
here, show foam cells are attached to, and embedded in,
fibrillar collagen (Figures 3B,D). TEM examination shows
phagocytosed fibrillar collagen in a foamy MNGC (Figure 3D;
Supplemental Figure 2A). In an enlargement of Figure 3B
(Supplemental Figure 2A) interstitial fibrillar collagen can
be seen among a group of ependymal cells, but none of
them showed phagocytosed collagen. Either phagocytosis
of the fibrillar collagen is accomplished only by the foamy
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macrophages, or reactive ependymal cell collagen uptake is
in the form of smaller peptides resulting from extracellular
degradation. In Figure 3F an image from a site in a zone farther
from the transection site where the interstitial collagen has
already been removed: no intracellular collagen was seen.
The ependymal cathepsin K production described here, and
ependymal MMP production characterized previously in Axolotl
cord regeneration, show that ependymal cells can participate
actively in ECM degradation mediated by secreted proteases
[Figure 11; (20)]. Foamy macrophages are known to produce
MMP9 and cathepsin K in diseases including atherosclerosis, and
MMP9 in multiple sclerosis (53, 108, 109).
Axolotl foamy macrophages and smaller MNGCs participate
in ECM removal by secretion of cathepsin K as well as
phagocytosis (Figures 3D, 11A–C,E; Supplemental Figure 2A).
MNGCs are seen in or on the reactive meninges (Figures 1G,H,
2D, 3A,B) and are known to participate in ECM degradation
in other system including MNGC tumors (32, 52). In our
primary tissue culture system, smaller MNGC actively produce
cathepsin K, while all of the foam cells do so (Figure 11). A full
understanding of the ECM proteolytic repertoire of cord lesion
site MNGCs will require much larger numbers in future studies
involving stimulated fusion in vitro.
ECM Synthesis
The participation of ependymal cell endfeet in reforming
the glia limitans has long suggested that they are producing
ECM in later stages of the regeneration process (2). The
expectation regarding ECM production by meningeal foam
cells is not at all clear. In a few experimental disease-related
models, a fibrotic role has been indicated for macrophages.
This includes exposure of human macrophages to native LDL
which stimulates proteoglycan secretion, a phenomenon with
implications for vascular wall trapping of apolipoprotein B-
containing lipoproteins in atherosclerotic plaques (110). This
phenomenon may be related to the production of a proteoglycan
form of macrophage colony stimulating factor in atherosclerotic
plaque macrophages (111). In mice with surgical sponge-induced
granulomas, and in atherosclerotic plaques, a variety of genes
associated with fibrosis are expressed in transcriptome analysis:
several collagen peptides and the small proteoglycans decorin and
biglycan (112). This expression is higher in foamy macrophages
vs. non-foamy macrophages (112).
The in vitro 3H-glucosamine uptake results presented here
suggest that ependymal cells are producing glycosaminoglycans
and proteoglycans during the ependymal outgrowth process,
depositing new ECM even as they are engaging in lesion
site matrix turnover (Figures 14A,C). The foamy macrophages,
however, show no evidence of ECM production from the 3H-
glucosamine uptake studies (Figures 14B,C).
Foamy Macrophage/Ependymal
Interactions: Beneficial to Regeneration or
Not?
In mammalian SCI, macrophages support scar formation and
inhibit axonal regrowth (55, 113, 114). Macrophages are required
in Axolotl limb and heart regeneration, so there is evidence that
innate immune system cells can have a positive role in urodele
regeneration (115, 116). In mouse heart, this positive role for
macrophages does not extend beyond the neonatal stage (117).
Less is known about macrophages and macrophage/target cell
interactions in urodele spinal cord regeneration. A study using
lectin probes shows macrophages within the injured Axolotl
spinal cord (36). In the newt studies by Zukor et al. (12), TEM
examination shows macrophages in contact with neurons in
an early stage of axonal regrowth called “wisping,” as well as
being present in the reactive meninges (12). In the Zukor et al.,
Figure 7D, a lipid-laden macrophage that could be a foam cells
is shown in contact with an axon, and foam cell-like white blood
cells are shown in the reactive meninges (12), Figure 7C. Though
not identified as such, foamy macrophages may be present in the
regenerating newt cord.
The present study examined the interaction between
foamy macrophages and ependymal cells (Figures 13, 14).
Mononucleated foamy macrophages were abundant in Axolotl
cord lesion site tissue in situ and in vitro (Figures 2B,E, 6C,
13C). Statistical analysis showed a highly significant association
of the presence of foamy macrophages with an increased degree
of dispersal of ependymal cells in vitro (Figures 2E, 5A,C, 13,
14). It is not known whether the interaction involves cell-cell
contact or secreted factors.
The co-migration of foamy macrophages and ependymal
cells was strong during the period of adult Axolotl cord
gap regeneration corresponding to mesenchymal ependymal
outgrowth (2 weeks, Figures 13A–D), while at 4 weeks of
regeneration, when the ependymal cells from cranial and caudal
stumps have reconnected, the foam cells were no longer
present (Figure 13E). It is not yet known whether the foamy
macrophages andMNGCs are excluded to the periphery with the
meninges, undergo cell death or both.
The position of these cells on and within the reactivemeninges
investing the regenerating stumps suggests a model in which the
foam cells and smaller MNGCs act on the invasive meninges
from the “outside-in,” while the ependymal cells act from within
the cord into the lesion site to remove fibrotic meningeal ECM
[Figures 1E–H, 2A,B, 15A; (16, 20)]. Because they are attached
to and within the invasive meninges, the foamy macrophages are
concentrated in the lesion site distal to the zone of ependymal
outgrowth. The ependymal cells grow out to meet and mix with
the foamy macrophages.
Foamy macrophages can release growth factors, such as FGF2
and TGFβ, that are bound by ECM (118). Decellularized human
meninges retains FGF2 and VEGF, suggesting that the release of
ECM-bound growth factors by the foamy macrophages proteases
could be of importance in the Axolotl cord lesion site (119).
Urodele ependymal cells respond to TGFβ and FGF2 (6, 120).
The relationship of foamy macrophages to ependymal
outgrowth, and their known activity, places the macrophages
in a position to open the way for ependymal cells through
ECM in vitro during ependymal outgrowth. In combination
with the ECM degrading and synthetic capacity of the reactive
ependymal cells, this juxtaposition of the foamy macrophages
and ependymal cells could help maintain directional outgrowth
across the lesion site.
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